Koers Orchid Ventures, Inc. Canadian Securities Exchange
Aandelen
ORCD
CA68573L2066
Farmaceutische producten
Omzet 2020 | 1,45 1,99 1,35 | Omzet 2021 | 3,72 5,11 3,48 | Marktkapitalisatie | 10,45 mln. 14,36 mln. 9,77 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -6 mln. -8,24 mln. -5,61 mln. | Nettowinst (verlies) 2021 | -3 mln. -4,12 mln. -2,8 mln. | EV/omzet 2020 | 2.373.049 x |
Nettoschuld 2020 | 363K 499K 340K | Nettoliquiditeiten 2021 | 1 mln. 1,38 mln. 938K | EV/omzet 2021 | 2.540.035 x |
K/w-verhouding 2020 |
-0,45
x | K/w-verhouding 2021 |
-2,02
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 79,11% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+18,02% | 246 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. | |
-4,38% | 156 mld. |